ElevateBio cuts a deal for Life Edit, adding genome engineering tech to support gene therapy pipeline

ElevateBio has enjoyed a close look at Life Edit Therapeutics over the past 11 months, with overlaps in the management team and involvement in its portfolio of cell and gene therapy companies giving it a chance to see how the genome editing specialist ticks. The experience has persuaded ElevateBio to buy the business.